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Abstract
Liver resection is the standard treatment for any liver lesion. Laparoscopic liver resection is associated with lower intra-operative
blood loss and fewer complications than open resection. Access to the posterior part of the right liver lobe is very uncomfortable
and difficult for surgeons due the anatomic position, especially when employing laparoscopic surgery. Based on these
experiences, a new laparoscopic device was developed that is capable of bending its long axis and allowing the application of
radiofrequency energy in areas that were not technically accessible. The device is equipped with four telescopic needle
electrodes that cause tissue coagulation after the delivery of radiofrequency energy. Ex vivo testing was performed in 2012 and
2014 at the University Hospital, Ostrava, on a porcine liver tissue. The main goal of this testing was to verify if the newly
proposed electrode layout was suitable for sufficient tissue coagulation and creating a safety zone around lesions. During the
ex vivo testing, the material of needle electrodes was improved to achieve the lowest possibility of adhesion. The power supply
was adjusted from 20 to 120 W and the ablation time, which varied from 10 to 110 s, was monitored. Subsequently, optimal
power delivery and time for coagulation was determined. This experimental study demonstrated the feasibility and safety of the
newly developed device. Based on the ex vivo testing, LARA-K1 can create a safety zone of coagulation. For further
assessment of the new device, an in vivo study should be performed.
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Introduction
Hepatic resection is currently the standard treatment
for liver lesions. The number of liver resections is increas-
ing due to increasing numbers of primary and secondary
tumors of liver parenchyma. Secondary tumors and metas-
tases in liver are mainly caused by gastrointestinal tumors,
most often by colorectal cancer. The incidence of colorectal
cancer is still increasing globally and thus the number of
liver metastases is increasing as well. Liver resection is
the first-line treatment option for patients with primary and
secondary liver tumors (1). Laparoscopic liver resection is
common and an easier liver surgery technique performed
in the recent times.
Radiofrequency energy is currently employed in the
treatment of numerous medical indications. Radiofrequency
is a high frequency alternating electrical current that creates
the desired clinical effect by passing through the tissue. It is
capable of heating the tissue around the active electrodes
(2,3). Radiofrequency energy has been used in medicine
since the 19th century (4). Radiofrequency ablation has
been incorporated into liver surgery for many years and has
become one of the standard methods in the treatment of
primary and secondary liver malignancies (5). There are
many studies that document the use of radiofrequency in
different ways to improve treatment protocols (6,7). Radio-
frequency-assisted liver resection represents a safe and
effective way of hepatic parenchyma transection (8). The
radiofrequency assisted resection technique is reported to
be associated with minimal blood loss, low blood transfu-
sion requirement, and reasonable postoperative morbidity
and mortality (9).
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Many studies have compared laparoscopic and open
surgery and reported that laparoscopic liver resection is
associated with lower intra-operative blood loss and fewer
complications and also laparoscopic hepatectomy has
similar short-term outcomes compared to open hepatec-
tomy (10). In cases of superficial and sub-superficial liver
lesions of anterior segments, laparoscopic resection can
be indicated as well as open surgery. There is no differ-
ence in survival rates after resection of colorectal liver
metastases by laparoscopic or open surgery (11). Laparo-
scopic resections are better tolerated, especially by patients
with liver cirrhosis (12).
According to anatomical division, segments VII and
VIII were traditionally considered unsuitable for the laparo-
scopic approach; however, Cho et al. (13,14) reported a
series of 36 patients with lesions in the postero-superior
segments, who underwent laparoscopic liver resections.
Modern surgery is trying to be as minimally invasive as
possible. Thus, efforts are being made to adapt the laparo-
scopic approach to an otherwise non-resectable tumor of
the posterior segments. The segments of the right posterior
lobe (VII and VIII) are difficult to access for laparoscopic
liver resection. The new proposed laparoscopic device
can simplify the access to those segments and aid non-
anatomical resections.
Based on the above information, a new device was
developed, which facilitated access to the posterior seg-
ments in the laparoscopic approach. Authors worked on
two projects using radiofrequency energy for development
of the new instrument, registered at the "Patent Protection
of Industrial Property". Two successful in vivo studies on
porcine models were also performed in cooperation with
University of Veterinary and Pharmaceutical University
Brno (15).
The main purpose of this ex vivo study was to deter-
mine if the prototype of the newly developed adjustable
device (LARA-K1) is functional and safe.
Material and Methods
The laparoscopic device was designed to fit the com-
monly used laparoscopic instruments. At the end of the
long axis of the device are four telescopic electrode needles.
These needles, manufactured from special structural steel,
can cause coagulation of the liver tissue after the delivery
of radiofrequency energy. The joint, which can bend into a
different angle, is located along the long axis of the device
(Figure 1).
With the telescopic needles and adjustable angle of
use, this device can readily access the posterior seg-
ments. Two rotating buttons allow very simple manipula-
tion of the adjustable possibilities. With the first button, we
can eject the four electrodes (needles) from 0 to 0.03 m
and the second button flexes the axis in angles from
0o to 60o. The connection with the current generator of
radiofrequency energy is considered a potential advantage.
There are no requirements for additional technical
instruments.
The initial phase of development included putting
together a set of medical requirements for the laparo-
scopic instrument and technical possibilities. During
2009–2012, a new device was developed, which, after its
introduction into the abdominal cavity through a laparo-
scopic trocar, could bend its long axis and eject the
telescopic needles to the required position. This technical
arrangement allows the application of radiofrequency energy
in areas that are currently inaccessible. The technical con-
struction of the prototype was performed by experts from
the Department of Robotics of the Technical University of
Ostrava (Figure 2).
Ex vivo testing was performed in 2012–2014 in the
experimental surgery theater at the University of Ostrava
on porcine liver tissue because of the similarities in
structure to the human liver. The main goal of the testing
was to evaluate if the newly proposed electrode layout
was suitable for sufficient tissue coagulation, creating a
Figure 1. LARA-K1. Functional prototype with angled end in the
long axis.
Figure 2. Ex vivo study. Application of the new laparoscopic
device caused coagulation necrosis in the liver tissue.
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safety zone around the lesion. Another goal of the study
was to discover any potential faults. The laparoscopic
simulator was used to determine the accuracy of manipu-
lation (Figure 3).
During the ex vivo testing, settings of power delivery,
depth of the puncture of electrodes, time required to create
a safety zone of coagulation necrosis, and the adhesiveness
of electrode needles were monitored.
The instrument was connected to a commonly used
radiofrequency generator. Thermal camera FLUKE Ti25
(Fluke Corporation, USA) was used to control the thermal
distribution of this device.
Results
During the ex vivo testing, many small objectives were
accomplished. The material of the electrode needles was
improved to structural steel with a special coating, which
can decrease the adhesiveness of electrodes to the zero
point. The optimal power delivery from the commonly used
radiofrequency generator was established. The time required
to coagulate the liver tissue depended on the delivered power.
Many trials were performed to set the time of coagulation
according to the power supply. Ablation time was from 10 to
110 s and power supply was from 20 to 120 W. The
optimal delivery power and time, which are required to
create a safety zone of coagulation necrosis in liver
parenchyma, was determined.
The optimal delivery power from the standard radio-
frequency generator was set to 90 W with a time of 14 s
on average to sufficiently coagulate the liver tissue. The
optional material for electrodes is structural steel with a
special coating, which decreases the adhesiveness as
much as possible.
Discussion
This study was based on the application of knowledge
about radiofrequency energy for practical use in laparo-
scopic liver surgery. A newly adjustable laparoscopic device
was created, and an ex vivo study was performed for proof
of efficiency. This laparoscopic technique allows the
performance of a larger number of smaller liver resections
with minimal blood loss and less effect on the "healthy" liver
parenchyma (16,17).
Studies (18–20) confirmed significantly less blood loss
in laparoscopic liver surgery compared to laparotomy.
Another study with a large number of laparoscopically
operated patients showed the need for blood transfusion
in 0.7% compared to 8% in open surgery (21). The most
frequent indications for laparoscopic liver resection are
lesions in segments II–VI, especially for wedge resection,
segmentectomy or lateral left-side hemihepatectomy. Liver
segments I, VII, and VIII are traditionally considered inac-
cessible for laparoscopic approach due to their anatomical
position in relation to the other structures.
This experimental study demonstrated the feasibility
and safety of the newly developed laparoscopic adjust-
able device. Testing the device on liver without blood
flow and other properties of the in vivo liver are potential
limitations. Therefore, it is necessary to test the device in an
in vivo study on laboratory animals. By using the laparo-
scopic simulator, we confirmed that manipulation with the
newly designed device LARA-K1 is satisfactory in the liver
with blood flow.
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